Reuters logo
BRIEF-Ergomed and Boryung Pharmaceutical Co enter agreement to commercialise Ergomed's haemostat products in South Korea
September 27, 2017 / 6:27 AM / 3 months ago

BRIEF-Ergomed and Boryung Pharmaceutical Co enter agreement to commercialise Ergomed's haemostat products in South Korea

Sept 27 (Reuters) - ERGOMED:

* SAYS CO AND BORYUNG PHARMACEUTICAL CO ANNOUNCE AGREEMENT TO COMMERCIALISE ERGOMED‘S HAEMOSTAT PRODUCTS PEPROSTAT AND READYFLOW IN SOUTH KOREA Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below